BioVaxys Technology Corp.
BVAXF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $4 | $157 | $212 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $470 | $468 | $436 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,383 | $626 | $656 | $653 |
| Total Curr. Assets | $1,387 | $1,100 | $1,281 | $1,301 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,387 | $1,100 | $1,281 | $1,301 |
| Liabilities | – | – | – | – |
| Payables | $2,472 | $1,524 | $1,499 | $1,557 |
| Short-Term Debt | $134 | $134 | $68 | $68 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,422 | $2,173 | $1,457 | $1,596 |
| Total Curr. Liab. | $5,028 | $3,831 | $3,024 | $3,221 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5,028 | $3,831 | $3,024 | $3,221 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $28,590 | $28,590 | $28,261 | $27,044 |
| Retained Earnings | -$34,547 | -$33,637 | -$32,321 | -$31,250 |
| AOCI | $2,317 | $2,311 | $2,311 | $2,263 |
| Other Equity | $0 | $6 | $6 | $23 |
| Total Equity | -$3,641 | -$2,731 | -$1,743 | -$1,920 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,387 | $1,100 | $1,281 | $1,301 |
| Net Debt | $130 | $129 | -$90 | -$144 |